Background Antipsychotics are widely used to manage behavioral disorders in patients with
dementia. Recently, serious concerns have been raised about the stroke and mortality risk of …

Background/Aims: To evaluate whether dementia patients prescribed antipsychotic drugs
have a higher mortality compared to unexposed patients, and to investigate whether there …

Background. The purpose of this study was to investigate the risk of death among elderly
outpatients (> 65 years) with a dementia diagnosis treated with atypical antipsychotics …

Purpose Since the beginning of the 21st century, serious adverse events and an increased
risk of mortality have been documented in patients with dementia treated with antipsychotics …

Purpose To estimate the association between use of typical and atypical antipsychotics and
all‐cause mortality in a population of demented outpatients. Methods The study cohort …

Objective To investigate short-and long-term mortality risk associated with the use of
antipsychotics in dementia outpatients, assessing the risk over specific time frames and …

Objective: A recent meta-analysis has indicated that, in patients with dementia, the use of
atypical antipsychotics is associated with an excess mortality. Later observational studies …

Background and objectives: The use of risperidone or olanzapine to treat behavioral
problems associated with dementia is no longer recommended in the UK because of the …

OBJECTIVES: To estimate mortality risk associated with individual commonly prescribed
antipsychotics. DESIGN: Five‐year retrospective study. SETTING: Veterans national …

Background Antipsychotics are prescribed to treat various symptoms in older adults,
however, their safety in this context has not been fully evaluated. The objective was to …